Cited by 58Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesCriminal Justice and Corrections Analysis

A Multisite Pilot Study of Extended-Release Injectable Naltrexone Treatment for Previously Opioid-Dependent Parolees and Probationers

Open access
Coviello, Donna M., Cornish, James W., Lynch, Kevin G., Boney, Tamara Y., Clark, Cynthia A., Lee, Joshua D., Friedmann, Peter D., Nunes, Edward V. +5 more·2012·Substance Abuse

Abstract

A feasibility study was conducted to pilot test the ability of 5 sites to recruit, treat, and retain opioid-dependent offenders in a trial of extended-release injectable naltrexone (XR-NTX). The participants, 61 previously opioid-dependent individuals under legal supervision in the community, received up to 6 monthly injections of Depotrex brand naltrexone and completed a 6-month follow-up interview. Six-month outcomes showed that those who completed treatment had significantly fewer opioid-positive urines and were less likely to have been incarcerated than those who had not completed treatment. The findings indicate that XR-NTX holds promise as a feasible, effective treatment option for opioid-dependent offenders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/08897077.2011.609438

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A prior single-group pilot study at the same five sites showed that Depotrex, an extended-release naltrexone formulation, was feasible as a treatment option for outpatient parolees and probationers.

    “A pilot study that was performed at the same five sites that participated in this trial used a single-group observational cohort design and showed the feasibility of using Depotrex, an alternative formulation of extended-release naltrexone, as a treatment option for outpatient parolees and probationers.13”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [2]Inciardi J War on Drugs IV 4 Boston Pearson 2008
  2. [3]Kinlock TW Gordon MS Schwartz RP Ruiz P Strain E Incarcerated populations Lowinson & Ruiz’s Substance Abuse: A Comprehensive Textbook 5 Lippincott Williams & Wilkins In press
  3. [9]Schwartz R Mitchell S Gordon M Kinlock T Leukefeld C Gregrich J Pharmocotherapy Handbook on Evidence Based Substance Abuse Treatment Practice in Criminal Justice Settings Springer Publishing In press

Cited by

Sorted by citations

Authors
Coviello, D. M., Cornish, J. W., Lynch, K. G., Boney, T. Y., Clark, C. A., Lee, J. D., Friedmann, P. D., Nunes, E. V., Kinlock, T. W., Gordon, M. S., Schwartz, R. P., Nuwayser, E. S., & O'Brien, C. P.
Affiliations
  • University of Pennsylvania (US)
  • Philadelphia VA Medical Center (US)
  • Bellevue Hospital Center (US)
  • Brown University (US)
  • Columbia University (US)
  • Friends Research Institute (US)
  • Biotek, Inc., Woburn, Massachusetts, USA
  • University of Pennsylvania, Philadelphia, Pennsylvania, USA
Corresponding author
Coviello, Donna M.
Venue
Substance Abuse
Published
2012-01
Volume
33
Issue
1
Pages
48-59
ISSN
  • 0889-7077 (ISSN-L)
  • 1547-0164
OpenAlex
W2024278700
Cited by
58
References
45
Citations by year
2022: 2 · 2021: 6 · 2020: 4 · 2019: 6 · 2018: 3 · 2017: 4 · 2016: 6 · 2015: 15 · 2014: 2 · 2013: 6 · 2012: 2
FWCI
7.73
Type
journal article
Language
en
Open access
Locations
  • Substance Abuse (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Drug Abuse (R01-DA-012268-05, R01DA012268)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Social Sciences › Sociology and Political Science › Criminal Justice and Corrections Analysis
Keywords
opioid use disorder, parolees, probationers, offender treatment, treatment retention, incarceration, feasibility, community supervision
MeSH terms
Adult, Delayed-Action Preparations, Feasibility Studies, Female, Follow-Up Studies, Humans, Injections, Injections, Subcutaneous, Male, Middle Aged, Naltrexone, Narcotic Antagonists, Opioid-Related Disorders, Pilot Projects, Prisoners, Young Adult, Opiate Substitution Treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review